Novel actions of inverse agonists on 5-HT(2C) receptor systems

Molecular Pharmacology

Volumn 55, Issue 5, 1999, Pages 863-872

  Berg, Kelly A ^a   Stout, Brian D ^a   Cropper, Jodie D ^a   Maayani, Saul ^b   Clarke, William P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; CLOZAPINE; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; KETANSERIN; MESULERGINE; MIANSERIN; PURINE RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME INHIBITION; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CHO CELLS; CRICETINAE; HUMANS; INDOLES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION;

EID: 0032907370     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Barker EL and Sanders-Bush E (1993) 5-Hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and n(-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Mol Pharmacol 44:725-730.
2. Barker EL, Westphal RS, Schmidt D and Sanders-Bush E (1994) Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem 269:11687-11690.
3. Berg KA, Clarke WP, Chen YB, Ebersole BJ, MacKay RDG and Maayani S (1994a) 5-hydroxytryptamine type 2A receptors regulate cAMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms. Mol Pharmacol 45:826-836.
4. Berg KA, Clarke WP, Sailstad C, Saltzman A and Maayani S (1994b) Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol Pharmacol 46:477-485.
5. 1B-like receptor function via arachidonic acid metabolism. Mol Pharmacol 50:1017-1023.
6. Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P and Clarke WP (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94-104.
7. Black JW and Shankley NP (1995) Inverse agonists exposed. Nature (London) 374:214-215.
8. Chidiac P, Nouet S and Bouvier M (1996) Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor. Mol Pharmacol 50:662-669.
9. Cockcroft S and Thomas GMH (1992) Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J 288:1-14.
10. Costa T, Ogino Y, Munson PJ, Onaran HO and Rodbard D (1992) Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: Thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol 41:549-560.
11. Felder CC, Kanterman RY, Ma AL and Axelrod J (1990) Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis Proc Natl Acad Sci USA 87:2187-2191.
12. Fields TA and Casey PJ (1997) Signalling functions and biochemical properties of pertussis toxin-resistant G proteins. Biochem J 321:561-571.
13. Gether U, Ballesteros JA, Seifert R, Sanders-Bush E, Weinstein H and Kobilka BK (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272:2587-2590.
14. 2C receptor stimulates cyclic GMP formation in choroid plexus. J Neurochem 64:199-205.
15. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CE and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
16. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expressions systems. Pharmacol Rev 48:413-463.
17. 2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 117:427-434.
18. Labrecque J, Fargin A, Bouvier M, Chidiac P and Dennis M (1995) Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Mol Pharmacol 48:150-159.
19. Lee TW, Cotecchia S and Milligan G ( 1997) Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster alpha1B-adrenoceptor by ligands that act as inverse agonists. Biochem J 325:733-739.
20. Leff P (1995) The two-state model of receptor activation. Trends Pharmacol Sci 16:89-97.
21. Leff P, Scaramellini C, Law C and McKechnie K (1997) A three-state model of agonist action. Trends Pharmacol Sci 18:355-362.
22. Lohse MJ (1993) Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1179:171-188.
23. Lowry OH, Rosenbrough NJ and Farr AL (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
24. MacEwan DJ and Milligan G (1996a) Inverse agonist-induced up-regulation of the human beta2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells Mol Pharmacol 50:1479-1486.
25. MacEwan DJ and Milligan G (1996b) Up-regulation of a constitutively active form of the beta2-adrenoceptor by sustained treatment with inverse agonists but not antagonists. FEBS Lett 399:108-112.
26. Milligan G and Bond RA (1997) Inverse agonism and the regulation of receptor number. Trends Pharmacol Sci 18:468-474.
27. Milligan G, Bond RA and Lee M (1995) Inverse agonism: Pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 16:10-13.
28. 11α equally and non-selectively FEBS Lett 324:241-245.
29. Offermanns S and Simon MI (1996) Organization of transmembrane signalling by heterotrimeric G proteins. Cancer Surv 27:177-198.
30. Pei G, Samama P, Lohse M, Wang M, Codina J and Lefkowitz RJ (1994) A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc Natl Acad Sci USA 91:2699-2702.
31. Perez DM, Hwa J, Gaivin R, Mathur M, Brown F and Graham RM (1996) Constitutive activation of a single effector pathway: Evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol 49:112-122.
32. Pranzatelli MR, Murthy JN and Tailor PT (1993) Novel regulation of 5-HTic receptors: Down-regulation induced both by 5-HTic/2 receptor agonists and antagonists Eur J Pharmacol 244:1-5.
33. Rhee SG and Bae YS (1997) Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem 272:15045-15048.
34. Roettger BF, Ghanekar D, Rao R, Toledo C, Yingling J, Pinon D and Miller LJ (1997) Antagonist-stimulated internalization of the G protein-coupled cholescystokinin receptor. Mol Pharmacol 51:357-362.
35. Samama P, Bond RA, Rockman HA, Milano CA and Lefkowitz RJ (1997) Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: Pharmacological creation of a phenotype in transgenic mice. Proc Natl Acad Sci USA 94:137-141.
36. Samama P, Cotecchia S, Costa T and Lefkowitz RJ (1993) A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4636.
37. ic receptors in choroid plexus. J Pharmacol Exp Ther 247:169-173.
38. Schütz W and Freissmuth M (1992) Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol Sci 13:376-380.
39. 11α, equally. Mol Pharmacol 46:1-7.
40. Smit MJ, Leurs R, Alewijnse AE, Blauw J, Van Nieuw Amerongen GP, Van De Vrede Y, Roovers E and Timmerman H (1996) Inverse agonism of histamine H2 antagonist accounts for up-regulation of spontaneously active histamine H2 receptors. free Natl Acad Sci USA 93:6802-6807.
41. Wadsworth SJ, Gebauer G, van Rossum GD and Dhanasekaran N (1997) Ras-dependent signaling by the GTPase-deficient mutant of Galpha12. J Biol Chem 272:28829-28832.
42. 2-adrenergic receptor. J Biol Chem 273:3401-3407.